Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bloomsbury Bioseed Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 2
Rounds per year 0.09
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Medical
  • Health Care
  • Medical Device
  • Information Technology
  • Pharmaceutical
Summary

Bloomsbury Bioseed Fund is the famous VC, which was founded in 1999. The leading representative office of defined VC is situated in the London. The venture was found in Europe in United Kingdom.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Information Technology, Innovation Management. Among the most popular portfolio startups of the fund, we may highlight Endomag, Canbex Therapeutics.

The top amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2011. Deals in the range of 1 - 5 millions dollars are the general things for fund.

The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, UCLB, Sussex Place Ventures. In the next rounds fund is usually obtained by New Wave Ventures, Wellcome Trust, UCLB.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bleu Capital New York, New York, United States
BPI Capital Corporation Makati, Manila, Philippines
China Literature Beijing, Beijing, China
DNB Norway, Oslo
Ewert Leaf Labs Australia, South Melbourne, Victoria
HB Realty Investments, Inc. -
Huijun Venture Capital China, Shanghai
Indigo 7 Ventures -
Investitions- und Strukturbank Rheinland-Pfalz Germany, Mainz, Rheinland-Pfalz
Ionis Pharmaceuticals California, Carlsbad, United States
Proto Accelerator Lansing, Michigan, United States
RBC Canada, Ontario, Toronto
Ruishuo Capital China, Shanghai
Silicon Solution Ventures -
Silverblue -
Skeleton Technologies Estonia, Harjumaa, Tallinn
Startup Grind California, San Francisco, United States
Taihe Entertainment Group Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Endomag

Health Care
Information Technology
Medical
Medical Device
$1M05 Aug 2011 England

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bloomsbury Bioseed Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 2M
Rounds per year 0.09
Peak activity year 2011
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Endomag

Health Care
Information Technology
Medical
Medical Device
$1M05 Aug 2011 England
Crunchbase icon

Content report

The following text will be sent to our editors: